|
Volumn 125, Issue 4, 2006, Pages 647-649
|
Using Isoform-Specific Inhibitors to Target Lipid Kinases
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 MORPHOLINO 8 PHENYLCHROMONE;
ATM PROTEIN;
ATR PROTEIN;
DNA DEPENDENT PROTEIN KINASE;
INSULIN;
ISOENZYME;
KU 55933;
MAMMALIAN TARGET OF RAPAMYCIN;
MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR;
PHOSPHATIDYLINOSITOL 3 KINASE;
PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR;
PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE;
PI 103;
PIK 108;
PIK 39;
PIK 90;
PIK 93;
PROTEIN KINASE B;
PROTEIN P110;
TGX 286;
UNCLASSIFIED DRUG;
WORTMANNIN;
CANCER GROWTH;
CELL GROWTH;
CELL SURVIVAL;
DIABETES MELLITUS;
DRUG BINDING;
DRUG SELECTIVITY;
DRUG TARGETING;
ENZYME ACTIVATION;
ENZYME ACTIVITY;
ENZYME INHIBITION;
GENE DELETION;
GENE DISRUPTION;
GENE MUTATION;
GENE SEQUENCE;
GENE SILENCING;
GLIOMA;
GLUCOSE INTOLERANCE;
HUMAN;
IC 50;
KNOCKOUT GENE;
NONHUMAN;
PHENOTYPE;
PRINCIPAL COMPONENT ANALYSIS;
PRIORITY JOURNAL;
PROTEIN ANALYSIS;
PROTEIN EXPRESSION;
PROTEIN FAMILY;
PROTEIN FUNCTION;
PROTEIN PHOSPHORYLATION;
RNA INTERFERENCE;
SHORT SURVEY;
MAMMALIA;
|
EID: 33646687962
PISSN: 00928674
EISSN: None
Source Type: Journal
DOI: 10.1016/j.cell.2006.05.008 Document Type: Short Survey |
Times cited : (8)
|
References (10)
|